224 related articles for article (PubMed ID: 34925644)
21. High Expression of the Component 3a Receptor 1 (C3AR1) Gene in Stomach Adenocarcinomas Infers a Poor Prognosis and High Immune-Infiltration Levels.
Yang H; Li L; Liu X; Zhao Y
Med Sci Monit; 2021 Feb; 27():e927977. PubMed ID: 33539329
[TBL] [Abstract][Full Text] [Related]
22. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
Zhou F; Lin Q; Zheng Z
Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
[TBL] [Abstract][Full Text] [Related]
23. Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma.
Wu B; Fu L; Guo X; Hu H; Li Y; Shi Y; Zhang Y; Han S; Lv C; Tian Y
Front Immunol; 2023; 14():984816. PubMed ID: 36761750
[TBL] [Abstract][Full Text] [Related]
24. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
[TBL] [Abstract][Full Text] [Related]
25. Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma.
Chen X; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
Dis Markers; 2020; 2020():8880937. PubMed ID: 33224315
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma.
Guo Y; Wang ZW; Su WH; Chen J; Wang YL
Biomed Res Int; 2020; 2020():4145164. PubMed ID: 32685482
[TBL] [Abstract][Full Text] [Related]
27. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
Guo L; Liu D
Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
[TBL] [Abstract][Full Text] [Related]
28. The Regulatory Role of Neuropeptide Gene Glucagon in Colorectal Cancer: A Comprehensive Bioinformatic Analysis.
Du W; Miao Y; Zhang G; Luo G; Yang P; Chen F; Zhang B; Yang C; Li G; Chang J
Dis Markers; 2022; 2022():4262600. PubMed ID: 35340411
[TBL] [Abstract][Full Text] [Related]
29. Identification of a fatty acid metabolism-related gene signature to predict prognosis in stomach adenocarcinoma.
Liu L; Sun J; Zhong C; Zhang A; Wang G; Chen S; Zhang S; Wang M; Li L
Aging (Albany NY); 2024 May; 16(10):8552-8571. PubMed ID: 38742949
[TBL] [Abstract][Full Text] [Related]
30. Combined bioinformatics technology to explore pivot genes and related clinical prognosis in the development of gastric cancer.
Xu J; Wang X; Ke Q; Liao K; Wan Y; Zhang K; Zhang G; Wang X
Sci Rep; 2021 Jul; 11(1):15412. PubMed ID: 34326374
[TBL] [Abstract][Full Text] [Related]
31. FKBP10 functioned as a cancer-promoting factor mediates cell proliferation, invasion, and migration via regulating PI3K signaling pathway in stomach adenocarcinoma.
Wang RG; Zhang D; Zhao CH; Wang QL; Qu H; He QS
Kaohsiung J Med Sci; 2020 May; 36(5):311-317. PubMed ID: 31868996
[TBL] [Abstract][Full Text] [Related]
32. Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Hibdon ES; Razumilava N; Keeley TM; Wong G; Solanki S; Shah YM; Samuelson LC
Neoplasia; 2019 Jul; 21(7):702-712. PubMed ID: 31129492
[TBL] [Abstract][Full Text] [Related]
33. ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinoma.
Gu Z; Wang L; Yao X; Long Q; Lee K; Li J; Yue D; Yang S; Liu Y; Li N; Li Y
Cell Death Dis; 2020 Oct; 11(10):898. PubMed ID: 33093458
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of the immune and prognostic implication of MASP1 in stomach adenocarcinoma.
Zhang CH; Xu ZQ; Peng LL; Wang JJ; Gu HT
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6725-6741. PubMed ID: 36196721
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma.
Wang D; Wang QH; Luo T; Jia W; Wang J
World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549
[TBL] [Abstract][Full Text] [Related]
37. eEF2K as a novel metastatic and prognostic biomarker in gastric cancer patients.
Jiang M; Qi L; Jin K; Li L; Wu Y; Song D; Gan J; Huang M; Li Y; Song C
Pathol Res Pract; 2021 Sep; 225():153568. PubMed ID: 34352439
[TBL] [Abstract][Full Text] [Related]
38. JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma.
Meng L; Ding L; Yu Y; Li W
Biomed Res Int; 2020; 2020():7973568. PubMed ID: 33083484
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Notch Signaling During Osteogenic Differentiation in Human Osteosarcoma Cell Line MG63.
Ongaro A; Pellati A; Bagheri L; Rizzo P; Caliceti C; Massari L; De Mattei M
J Cell Physiol; 2016 Dec; 231(12):2652-63. PubMed ID: 26946465
[TBL] [Abstract][Full Text] [Related]
40. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma.
Huang Z; He A; Wang J; Lu H; Zhang R; Wu L; Feng Q
Aging (Albany NY); 2021 Jun; 13(12):16637-16655. PubMed ID: 34162762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]